NABULSI AZMI (Chief Operating Officer) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/17/2023ACC: 0001209191-23-042453
Officer· Chief Operating Officer
Since Oct 2019
-110K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
110K acquired · 220K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+110K
Price / share
—
Trade value
—
% of position
110.5%
7/14/2023
99.57K→209.57K
Total
Net shares
+110K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2023 | A · Award | +110K | — | — | 110.5% | 99.57K | 209.57K |
| Total | +110K | $0.00 | ||||||
Derivative Transactions2
Stock Option
Direct
Converts to
Common Stock
70K shares
Shares
−70K
Strike price
32.20
Held after
0.00
Exercisable
—
7/14/2023
Stock Option
Direct
Converts to
Common Stock
150K shares
Shares
−150K
Strike price
39.11
Held after
0.00
Exercisable
—
7/14/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock70K shares | 7/14/2023 | D · Disposition | −70K | 32.20 | — | 0.00 |
| Stock Option Direct | Common Stock150K shares | 7/14/2023 | D · Disposition | −150K | 39.11 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned785.70K
Common Stock
IndirectShares owned3.58K
Total
789.28K indirect789.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 785.70K | Indirect |
| Common Stock | 3.58K | Indirect |
| Total | 789.28K | 789.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported